UnitedHealth Group Incorporated (NYSE:UNH) CFO Sells $7,138,989.99 in Stock

UnitedHealth Group Incorporated (NYSE:UNHGet Rating) CFO John F. Rex sold 13,183 shares of the stock in a transaction that occurred on Friday, July 29th. The stock was sold at an average price of $541.53, for a total value of $7,138,989.99. Following the completion of the sale, the chief financial officer now owns 141,508 shares of the company’s stock, valued at approximately $76,630,827.24. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $542.34 on Monday. The stock’s 50-day simple moving average is $502.80 and its 200-day simple moving average is $497.45. UnitedHealth Group Incorporated has a 52 week low of $383.12 and a 52 week high of $553.29. The company has a market capitalization of $508.81 billion, a price-to-earnings ratio of 28.32, a PEG ratio of 1.64 and a beta of 0.77. The company has a quick ratio of 0.78, a current ratio of 0.77 and a debt-to-equity ratio of 0.60.

UnitedHealth Group (NYSE:UNHGet Rating) last announced its quarterly earnings data on Friday, July 15th. The healthcare conglomerate reported $5.57 EPS for the quarter, beating the consensus estimate of $5.24 by $0.33. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The business had revenue of $80.33 billion for the quarter, compared to the consensus estimate of $79.68 billion. During the same period in the previous year, the business earned $4.70 earnings per share. The business’s revenue was up 12.6% on a year-over-year basis. As a group, analysts expect that UnitedHealth Group Incorporated will post 21.84 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 28th. Investors of record on Monday, June 20th were given a $1.65 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.45. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.22%. The ex-dividend date of this dividend was Thursday, June 16th. UnitedHealth Group’s payout ratio is currently 34.46%.

Institutional Investors Weigh In On UnitedHealth Group

Hedge funds have recently made changes to their positions in the company. Outfitter Financial LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth about $25,000. Urban Wealth Management LLC bought a new stake in UnitedHealth Group during the second quarter worth approximately $29,000. Advocacy Wealth Management Services LLC increased its stake in UnitedHealth Group by 75.8% during the first quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock worth $30,000 after acquiring an additional 25 shares during the last quarter. Cascade Investment Advisors Inc. increased its stake in UnitedHealth Group by 100.0% during the first quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 30 shares during the last quarter. Finally, Rothschild & Co Wealth Management UK Ltd bought a new stake in UnitedHealth Group during the second quarter worth approximately $31,000. 87.48% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

UNH has been the subject of several research analyst reports. Royal Bank of Canada set a $563.00 price objective on UnitedHealth Group and gave the stock an “outperform” rating in a report on Monday, April 18th. SVB Leerink raised their price objective on UnitedHealth Group from $600.00 to $625.00 and gave the company an “outperform” rating in a research report on Monday, July 18th. Loop Capital assumed coverage on UnitedHealth Group in a report on Thursday, June 16th. They issued a “buy” rating and a $575.00 price objective for the company. Morgan Stanley lifted their price objective on UnitedHealth Group from $570.00 to $587.00 in a report on Monday, July 18th. Finally, Raymond James lifted their price objective on UnitedHealth Group from $540.00 to $620.00 and gave the stock a “strong-buy” rating in a report on Tuesday, April 19th. Three research analysts have rated the stock with a hold rating, sixteen have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $582.50.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Stories

Insider Buying and Selling by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.